Bill Miller - Miller Value Partners
Period:    Q1 2026
Portfolio date:    31 Mar 2026
No. of stocks:    55
Portfolio value:    $383,178,520
Holdings Activity Buys Sells    History
Holding/activity history for  Halozyme Therapeutics, Inc. (HALO)
← All HALO superinvestors
Period Shares % of Portfolio Activity % Change to Portfolio Price Value Filing
2020   Q1 0 0.00 Sell 100.00% 0.01 $12.71–22.06 · VW $18.60i SEC
2019   Q4 20,000 0.01 $17.75 $355,000 SEC
2019   Q3 20,000 0.01 $15.50 $310,000 SEC
2019   Q2 20,000 0.01 $17.20 $344,000 SEC
2019   Q1 20,000 0.01 $16.10 $322,000 SEC
2018   Q4 20,000 0.01 Reduce 88.24% 0.09 $13.24–18.76 · VW $15.76i $293,000 SEC
2018   Q3 170,000 0.10 $18.17 $3,089,000 SEC
2018   Q2 170,000 0.12 $16.87 $2,868,000 SEC
2018   Q1 170,000 0.15 $19.59 $3,330,000 SEC
2017   Q4 170,000 0.16 $20.26 $3,444,000 SEC
2017   Q3 170,000 0.14 Reduce 82.10% 0.44 $11.41–17.62 · VW $14.63i $2,953,000 SEC
2017   Q2 949,800 0.54 Buy 0.54 $11.51–15.05 · VW $13.07i $12,176,000 SEC
Price snapshot:
Current price$76.11
52-week low$55.64
52-week high$82.26